4d Molecular Therapeutics Stock In The News

FDMT Stock  USD 3.63  0.07  1.97%   
Our overall analysis of 4D Molecular's news coverage and content from conventional and social sources shows investors' bearish mood towards 4D Molecular Therapeutics. The specific impact of 4D Molecular news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of 4D Molecular's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using 4D Molecular headlines in addition to utilizing other, more conventional financial analysis modules. Check out 4D Molecular Backtesting and 4D Molecular Hype Analysis.

4D Molecular Today Top News and Investor Outlook

Yahoo News
4DMT to Host Corporate Webcast to Discus...
https://finance.yahoo.com/news/4dmt-host-corporate-webcast-discuss-130000529.html
 Neutral
Yahoo News
4D Molecular Therapeutics Inc CEO David Kirn Sells 5,696 Shares
https://finance.yahoo.com/news/4d-molecular-therapeutics-inc-ceo-030438491.html
 Bullish
Yahoo News
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
https://finance.yahoo.com/news/4dmt-receives-rare-pediatric-disease-130000264.html
 Neutral
Yahoo News
All You Need to Know About 4D Molecular Therapeutics, Inc. (FDMT) Rating Upgrade to Strong Buy
https://finance.yahoo.com/news/know-4d-molecular-therapeutics-inc-170006792.html
 Bullish
Yahoo News
4D Molecular Therapeutics Inc CEO David Kirn Sells 102,303 Shares
https://finance.yahoo.com/news/4d-molecular-therapeutics-inc-ceo-100219109.html
 Neutral
Yahoo News
Andreas Halvorsen Adjusts Position in 4D Molecular Therapeutics Inc
https://finance.yahoo.com/news/andreas-halvorsen-adjusts-position-4d-100248476.html
 Bullish
Yahoo News
Andreas Halvorsen's Firm Adjusts Position in 4D Molecular Therapeutics Inc
https://finance.yahoo.com/news/andreas-halvorsens-firm-adjusts-position-100248239.html
 Bullish
Yahoo News
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
https://finance.yahoo.com/news/4dmt-highlights-recent-clinical-pipeline-130000839.html
 Neutral
Yahoo News
4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases
https://finance.yahoo.com/news/4dmt-arbor-biotechnologies-establish-partnership-130100115.html
 Bullish
Yahoo News
4DMT Receives FDA Regenerative Medicine ...
https://finance.yahoo.com/news/4dmt-receives-fda-regenerative-medicine-130000258.html
 Bullish

4D Molecular Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide FDMT and other traded companies coverage with news coverage. We help investors stay connected with FDMT headlines for the 30th of March to make an informed investment decision based on correlating the impacts of news items on FDMT Stock performance. Please note that trading solely based on the 4D Molecular Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
4D Molecular's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help 4D Molecular Therapeutics investors visualize upcoming and past events in order to time the market based on 4D Molecular Therapeutics noise-free hype analysis.
4D Molecular stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the FDMT earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about 4D Molecular that are available to investors today. That information is available publicly through FDMT media outlets and privately through word of mouth or via FDMT internal channels. However, regardless of the origin, that massive amount of FDMT data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 4D Molecular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 4D Molecular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 4D Molecular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 4D Molecular alpha.

FDMT Largest EPS Surprises

Earnings surprises can significantly impact 4D Molecular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-08
2024-06-30-0.7-0.630.0710 
2024-05-09
2024-03-31-0.74-0.660.0810 
2024-11-07
2024-09-30-0.7-0.79-0.0912 
2022-11-08
2022-09-30-0.91-0.790.1213 
2023-11-09
2023-09-30-0.59-0.240.3559 
2021-08-12
2021-06-30-0.68-0.280.458 
View All Earnings Estimates

4D Molecular Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to 4D Molecular Therapeutics Stock. Current markets are strongly bearish. About 72% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
27th of March 2025
Leading Gene Therapy Biotech 4DMT Headlines RBCs Elite Ophthalmology Conference - StockTit...
at news.google.com 
Macroaxis News
11th of March 2025
Disposition of 11653 shares by Kirn David of 4D Molecular at 14.42 subject to Rule 16b-3
at MacroaxisInsider 
Macroaxis News
6th of March 2025
Acquisition by Fariborz Kamal of 178400 shares of 4D Molecular at 4.14 subject to Rule 16b...
at MacroaxisInsider 
news
3rd of March 2025
Royal Bank of Canada Lowers 4D Molecular Therapeutics Price Target to 35.00
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
28th of February 2025
4DMT Reports Full Year 2024 Financial Results, Operational Highl
at gurufocus.com 
news
13th of February 2025
Chardan Capital Has Lowered Expectations for 4D Molecular Therapeutics Stock Price
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
29th of January 2025
4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohor...
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards 4D Molecular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, 4D Molecular's short interest history, or implied volatility extrapolated from 4D Molecular options trading.

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.